Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.
Mehraj U, Ganai RA, Macha MA, Hamid A, Zargar MA, Bhat AA, et al. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: new challenges and therapeutic opportunities. Cell Oncol. 2021;44:1209–29. https://doi.org/10.1007/s13402-021-00634-9.
Tripathi M, Billet S, Bhowmick NA. Understanding the role of stromal fibroblasts in cancer progression. Cell Adhes Migr. 2012;6:231–5.
Zhang W, Wang J, Liu C, Li Y, Sun C, Wu J, et al. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis. J Transl Med. 2023;21:827. https://doi.org/10.1186/s12967-023-04714-2.
Shukla N, Naik A, Moryani K, Soni M, Shah J, Dave H. TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond. Life Sci. 2022;310:121011. https://doi.org/10.1016/j.lfs.2022.121011.
Shi X, Young CD, Zhou H, Wang X. Transforming growth Factor-β signaling in fibrotic diseases and Cancer-Associated fibroblasts. Biomolecules. 2020;10. https://doi.org/10.3390/biom10121666.
Ringuette Goulet C, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F. Exosomes induce fibroblast differentiation into Cancer-Associated fibroblasts through TGFβ signaling. Mol Cancer Res. 2018;16:1196–204. https://doi.org/10.1158/1541-7786.MCR-17-0784.
Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z, et al. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells. 2012;30:2810–9. https://doi.org/10.1002/stem.1251.
Rosenthal E, McCrory A, Talbert M, Young G, Murphy-Ullrich J, Gladson C. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts. Mol Carcinog. 2004;40:116–21. https://doi.org/10.1002/mc.20024.
Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol. 2003;29:397–404. https://doi.org/10.1165/rcmb.2003-0063OC.
Bussard KM, Spaeth E, Mutkus LA, Stumpf KA, Marini FC. 11 - Mesenchymal Stem Cell Transition to Tumor-Associated Stromal Cells Contributes to Cancer Progression. In: Bolontrade MF, García MGBT-MSC as TSM, editors., Boston: Academic Press; 2017, p. 253–73. https://doi.org/10.1016/B978-0-12-803102-5.00011-2.
Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care. 2013;22:407–8. https://doi.org/10.12968/jowc.2013.22.8.407.
Rockey DC, Weymouth N, Shi Z. Smooth muscle α actin (Acta2) and myofibroblast function during hepatic wound healing. PLoS ONE. 2013;8:e77166. https://doi.org/10.1371/journal.pone.0077166.
Darby IA, Laverdet B, Bonté F, Desmoulière A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014. https://doi.org/10.2147/CCID.S50046.
Webber J, Meran S, Steadman R, Phillips A. Hyaluronan orchestrates transforming growth factor-β1-dependent maintenance of myofibroblast phenotype. J Biol Chem. 2009;284:9083–92. https://doi.org/10.1074/jbc.M806989200.
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–9.
Deyell M, Garris CS, Laughney AM. Cancer metastasis as a non-healing wound. Br J Cancer. 2021;124:1491–502. https://doi.org/10.1038/s41416-021-01309-w.
Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer. 2000;83:164–70. https://doi.org/10.1054/bjoc.2000.1272.
Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A. 2000;97:5255–60. https://doi.org/10.1073/pnas.97.10.5255.
Versteeg HH, Arnold Spek C, Richel DJ, Peppelenbosch MP. Coagulation factors VIIa and Xa inhibit apoptosis and Anoikis. Oncogene. 2004;23:410–7. https://doi.org/10.1038/sj.onc.1207066.
Liu Y, Mueller BM. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun. 2006;344:1263–70. https://doi.org/10.1016/j.bbrc.2006.04.005.
Shaker H, Bundred NJ, Landberg G, Pritchard SA, Albadry H, Nicholson SL, et al. Breast cancer stromal clotting activation (Tissue factor and thrombin): A pre-invasive phenomena that is prognostic in invasion. Cancer Med. 2020;9:1768–78. https://doi.org/10.1002/cam4.2748.
Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ittai B-P, et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010;107:20009–14.
Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F. Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost. 2011;9(Suppl 1):306–15. https://doi.org/10.1111/j.1538-7836.2011.04318.x.
Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y, et al. Targeting the transforming growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer. 2010;9:122. https://doi.org/10.1186/1476-4598-9-122.
Torsello B, De Marco S, Bombelli S, Cifola I, Morabito I, Invernizzi L, et al. High glucose induces an activated state of partial epithelial-mesenchymal transition in human primary tubular cell cultures. PLoS ONE. 2023;18:e0279655. https://doi.org/10.1371/journal.pone.0279655.
Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815–22. https://doi.org/10.3892/ijmm.2016.2768.
Caneparo C, Chabaud S, Fradette J, Bolduc S. Evaluation of a Serum-Free medium for human epithelial and stromal cell culture. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms231710035.
Menz A, Gorbokon N, Viehweger F, Lennartz M, Hube-Magg C, Hornsteiner L, et al. Pan-keratin immunostaining in human tumors: A tissue microarray study of 15,940 tumors. Int J Surg Pathol. 2023;31:927–38. https://doi.org/10.1177/10668969221117243.
Haasters F, Prall WC, Anz D, Bourquin C, Pautke C, Endres S, et al. Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat. 2009;214:759–67. https://doi.org/10.1111/j.1469-7580.2009.01065.x.
Jin L, Qu Y, Gomez LJ, Chung S, Han B, Yue Y, et al. Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed. Cell Cult. 2018;9:11503–14.
Ilg MM, Lapthorn AR, Harding SL, Minhas T, Koduri G, Bustin SA. Development of a phenotypic screening assay to measure activation of cancer-associated Fi broblasts. 2025:1–13. https://doi.org/10.3389/fphar.2025.1526495.
Sandberg TP, Stuart MPME, Oosting J, Tollenaar RAEM, Sier CFM, Mesker WE. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer. 2019;19:284. https://doi.org/10.1186/s12885-019-5462-2.
Benyahia Z, Dussault N, Cayol M, Sigaud R, Delfino C, Tounsi A et al. Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion. Oncotarget. 2017;8:15744–62. https://doi.org/10.18632/oncotarget.14999.
Stapor PC, Sweat RS, Dashti DC, Betancourt AM, Murfee WL. Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res. 2014;51:163–74. https://doi.org/10.1159/000362276.
Bae S, Park CW, Son HK, Ju HK, Paik D, Jeon C-J, et al. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br J Haematol. 2008;142:827–30. https://doi.org/10.1111/j.1365-2141.2008.07241.x.
Zhang J, Sun D, Fu Q, Cao Q, Zhang H, Zhang K. Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment. Oncol Lett. 2016;12:644–50. https://doi.org/10.3892/ol.2016.4645.
Del Toro K, Licon-Munoz Y, Crabtree W, Oper T, Robbins C, Hines WC. Breast pericytes: a newly identified driver of tumor cell proliferation. Front Oncol. 2024;14:1455484. https://doi.org/10.3389/fonc.2024.1455484.
Buchsbaum RJ, Oh SY. Breast Cancer-Associated fibroblasts: where we are and where we need to go. Cancers (Basel). 2016;8:1–19. https://doi.org/10.3390/cancers8020019.
Ichim TE, O’Heeron P, Kesari S. Fibroblasts as a practical alternative to mesenchymal stem cells. J Transl Med. 2018;16:212. https://doi.org/10.1186/s12967-018-1536-1.
McErlain T, McCulla EC, Glass MJ, Ziemer LE, Branco CM, Murgai M. Pericytes require physiological oxygen tension to maintain phenotypic fidelity. Sci Rep. 2024;14:29581. https://doi.org/10.1038/s41598-024-80682-x.
Nikolits I, Nebel S, Egger D, Kreß S, Kasper C. Towards physiologic culture approaches to improve standard cultivation of mesenchymal stem cells. Cells. 2021;10:886. https://doi.org/10.3390/cells10040886.
Tigges U, Welser-Alves JV, Boroujerdi A, Milner R. A novel and simple method for culturing pericytes from mouse brain. Microvasc Res. 2012;84:74–80. https://doi.org/10.1016/j.mvr.2012.03.008.
Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, et al. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Am J Respir Cell Mol Biol. 2012. https://doi.org/10.1165/rcmb.2012-0097OC.
Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in Myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A. 1993;90:999–1003. https://doi.org/10.1073/pnas.90.3.999.
Landry NM, Rattan SG, Dixon IMC. An improved method of maintaining primary murine cardiac fibroblasts in Two-Dimensional cell culture. Sci Rep. 2019;9:1–13. https://doi.org/10.1038/s41598-019-49285-9.
Shamhart PE, Luther DJ, Adapala RK, Bryant JE, Petersen KA, Meszaros JG, et al. Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts. Can J Physiol Pharmacol. 2014;92:598–604. https://doi.org/10.1139/cjpp-2013-0490.
Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol. 2015;28:14–29. https://doi.org/10.1038/modpathol.2014.81.
Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer. 2018;18:19–32. https://doi.org/10.1038/nrc.2017.102.
Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017;8:1077. https://doi.org/10.1038/s41467-017-01027-z.
Chatterjee S, Basak P, Buchel E, Safneck J, Murphy LC, Mowat M, et al. Breast cancers activate stromal Fibroblast-Induced suppression of progenitors in adjacent normal tissue. Stem Cell Rep. 2018;10:196–211. https://doi.org/10.1016/j.stemcr.2017.11.002.
Comments (0)